Practical synthesis of d-[1-C]mannose, l-[1-C] and l-[6-C]fucose

The chemical synthesis of ¹³C-labeled mannose and fucose is important for the preparation of molecular probes used in the conformational study of the oligosaccharide portions of glycoproteins. A new method for the synthesis of the title [1-¹³C]-labeled compounds via the corresponding olefin compounds, which are in turn derived from d-mannitol or l-arabinose by efficient introduction of ¹³C, by the Wittig reaction using Ph₃P¹³CH₃I and n-BuLi, is described. The introduction of ¹³CH₃I to produce the [1-¹³C]- and [6-¹³C]-labeled compounds was accomplished in 62%, 56%, and 71% yields, respectively. All mannose and fucose protons, from H-1 to H-6, were observed by the HMQC-TOCSY technique using 1:1 mixtures of [1-¹³C]- and [6-¹³C]-labeled compounds.     

Chemoenzymatic synthesis of [3,9-C]-labeled NeuAc and KDN

The chemoenzymatic synthesis of ¹³C-labeled sialic acid (NeuAc) and 3-deoxy-d-glycero-d-galacto-2-nonulosonic acid (KDN) as useful molecular probes for studying the conformation of sialyl or KDN oligosaccharides attached to proteins was performed by using [6-¹³C]-ManNAc, [6-¹³C]-Man and [3-¹³C]-pyruvic acid sodium salt. In the synthesis of the compounds, 5,6-anhydro intermediates were found to easily provide not only 6-¹³C-labeled but also 5-, and 6-modified NeuAc and KDN analogs. Furthermore, it was demonstrated that identical results are obtained by NMR for both [3,9-¹³C]-NeuAc and 1:1 mixtures of [3-¹³C]- and [9-¹³C]-NeuAc.     

Practical synthesis of [1-C]- and [6-C]-d-galactose

The chemical synthesis of ¹³C-labeled d-galactose as useful molecular probes for studying the conformation of oligosaccharides attached to proteins was performed. The method for synthesizing the title labeled compounds was newly developed via the corresponding 1-ene and 5-ene compounds derived from 1,2:5,6-di-O-isoproppylidene-α-d-galactofuranose by considering the efficient introduction of the atom. All protons of galactose from H-1 to H-6 were observed by the HMQC-HOHAHA technique using 1:1 mixtures of methyl [1-¹³C]- and [6-¹³C]-β-d-galactopyranoside, which were prepared from the title compounds.     

Biosynthesis of the benz[α]anthraquinone antibiotic PD 116198

The labeling pattern obtained from incorporation of a mixture of sodium [1-¹³C]- and [s-¹³C]acetates has confirmed the irregular derivation of the benz[α]anthraquinone skeleton of the angucycline antibiotic PD 116198. Subsequent incorporation of sodium [1-¹³C, ¹⁸O₂]-, and [1-¹³C, 2-²H₃]acetates and of ¹⁸O₂ have revealed the origins of the hydrogen and oxygen atoms of the antibiotic. The possibility of a “two-chain” biosynthesis was tested by feeding ²H-labeled orsellinates; however, no incorporation was detected. PD 116198 seems most plausibly derived by rearrangement of an initially-formed linear tetracyclic intermediate.     

An asymmetric synthesis of l-[3-C]phenylalanine and l-[3-C]tyrosine from [C]carbon monoxide

-[3-¹³C]Phenylalanine and -[3-¹³C]tyrosine were synthesized. [α-¹³C]Benzyl bromides were prepared from [¹³C]carbon monoxide via the palladium-catalyzed carboalkoxylation of aryl halides. The asymmetric carbon corresponding to the 2-position in phenylalanine was introduced by the diastereoselective alkylation of Dellaria's oxazinone with [α-¹³C]benzyl bromides. Finally, ethanolysis, deprotection, hydrogenolysis and acid hydrolysis of the resulting alkylated oxazinones gave -[3-¹³C]phenylalanine and -[3-¹³C]tyrosine in high optical purity.     

A new convenient method for the synthesis of [2-C]thymine utilizing [C]phosgene

β-(N-Benzoylamino)methacrylamide, a key intermediate for the preparation of [2-¹¹C]thymine, was synthesized in three steps from ethyl α-formylpropionate and NH₃. Reaction of the alkali metal salts of β-(N-benzoylamino)methacrylamide with [¹¹C]phosgene gave [2-¹¹C]thymine. The yield of [2-¹¹C]thymine was 362 ± 53 MBq at EOS (n = 3) (18 MeV proton beam; 10 μA, 10 min). The total synthesis was accomplished in just 16 min from the end of bombardment.     

[6-C]-(2S,4S)-5-Chloroleucine: synthesis and incubation studies with cultures of the cyanobacterium, Lyngbya majuscula

[6-¹³C]-(2S,4S)-5-Chloroleucine 12 was prepared in six steps and 26% overall yield from protected l-glutamic acid using ¹³CH₃I as the source of isotopic label. On feeding 12 to cultures of L. majuscula no incorporation of isotopic label into the trichlorinated marine natural product barbamide was detected. The synthesis of a novel dichloroleucine derivative 16 is also described.     

Fused heterocycles. 8 . An efficient procedure for the stereoselective synthesis of trans-2,3,3a,4-tetrahydro-3-aryl-2-phenyl[1]benzopyrano[4,3-c]pyrazoles and their [1]benzothiopyrano analogues

Stereoselective synthesis of trans-2,3,3a,4-tetrahydro-3-aryl-2-phenyl[1]benzopyrano[4,3-c]pyrazoles 13–18 and their [1]benzothiopyrano analogues 19–24 has been performed by the reaction of 3-arylidenechromanones 1–6 and 3-arylidene-1-thiochromanones 7–12 with phenylhydrazine in hot pyridine. The structure and stereochemistry of the compounds prepared have been elucidated by ir, ^lH and ¹³C nmr measurements.     

Biosynthesis of the antibiotic verrucarin E use of [1-13C]-, [2-13C]-, [1,2-13C]- and [2-13C, 2-2H3]-acetates. Verrucarins and roridins, 37th communication [1]

The origin of the carbon skeleton of verrucarin E (1) from acetate as precursor is confirmed. Incorporation studies with [1,2-¹³C]-acetate have demonstrated that two acetoacetate units couple together as shown in pattern A (Scheme 2) and not as in B . Analysis of the deuterium distribution in both verrucarin E (1) isolated after the incorporation of [2-¹³C,2-²H₃]-acetate and in sodium acetate obtained after Kuhn-Roth oxidation of the metabolite demonstrated that C(7) is derived from the starter unit of one of the acetoacetate moieties. The deuterium exchange in verrucarin E (1) occurring during fermentation was investigated.     

Synthesis of [1-15N,2-13C]-labeled difloxacin

Abstract  

The synthesis of [1-¹⁵N,2-¹³C]-difloxacin, an arylfluoroquinolone antibacterial agent, is reported. As a crucial initial step, the starting materials ethyl 2,4,5-trifluorobenzoylacetate, [formyl-¹³C]-triethyl orthoformate, and [¹⁵N]-4-fluoroaniline were reacted to ethyl [¹⁵N,3-¹³C]-3-(4-fluoroanilino)-2-(2,4,5-trifluorobenzoyl)acrylate. After cyclization and ester cleavage, the resulting intermediate was reacted with 1-methylpiperazine to [1-¹⁵N,2-¹³C]-1-(4-fluorophenyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylate, i.e., [1-¹⁵N,2-¹³C]-difloxacin. The overall yield was 62% based on the non-labeled and 43% based on the labeled starting materials (both used in 1.4 molar excess). The product was identified by ¹H-, ¹³C-, and ¹⁵N-NMR spectroscopy and by cochromatography (TLC, HPLC) with an authentic reference; its purity (HPLC) was above 98%. Prior to synthesis of [1-¹⁵N,2-¹³C]-difloxacin, non-labeled difloxacin was synthesized in order to optimize procedures and to identify and characterize all intermediates.     

Order-Unity 13C Nuclear Polarization of [1-13C]Pyruvate in Seconds and the Interplay of Water and SABRE Enhancement

Signal Amplification By Reversible Exchange in SHield Enabled Alignment Transfer (SABRE-SHEATH) is investigated to achieve rapid hyperpolarization of ¹³C₁ spins of [1-¹³C]pyruvate, using parahydrogen as the source of nuclear spin order. Pyruvate exchange with an iridium polarization transfer complex can be modulated via a sensitive interplay between temperature and co-ligation of DMSO and H₂O. Order-unity ¹³C (>50 %) polarization of catalyst-bound [1-¹³C]pyruvate is achieved in less than 30 s by restricting the chemical exchange of [1-¹³C]pyruvate at lower temperatures. On the catalyst bound pyruvate, 39 % polarization is measured using a 1.4 T NMR spectrometer, and extrapolated to >50 % at the end of build-up in situ. The highest measured polarization of a 30-mM pyruvate sample, including free and bound pyruvate is 13 % when using 20 mM DMSO and 0.5 M water in CD₃OD. Efficient ¹³C polarization is also enabled by favorable relaxation dynamics in sub-microtesla magnetic fields, as indicated by fast polarization buildup rates compared to the T₁ spin-relaxation rates (e. g., ∼0.2 s⁻¹ versus ∼0.1 s⁻¹, respectively, for a 6 mM catalyst-[1-¹³C]pyruvate sample). Finally, the catalyst-bound hyperpolarized [1-¹³C]pyruvate can be released rapidly by cycling the temperature and/or by optimizing the amount of water, paving the way to future biomedical applications of hyperpolarized [1-¹³C]pyruvate produced via comparatively fast and simple SABRE-SHEATH-based approaches.     

Total assignment of the 1H and 13C NMR spectra of pyrrolizino-[3,4,5-a,b]isoquinoline,benzo[1,2]pyrrolizino[3,4,5-a,b]isoquinoline and 2-methylthiopyrrolizino[3,4,5-a,b]isoquinoline

The total ¹H and ¹³C nmr spectral assignments of pyrrolizino[3,4,5-a,b]isoquinoline, benzo-[1,2]pyrrolizino[3,4,5-a,b]isoquinoline and 2-methylthiopyrrolizino[3,4,5-a,b]isoquinoline are reported. The concerted use of the COSY, HMQC, HMBC and nOe-difference experiments is used to generate total assignments of the ¹H and ¹³C nmr spectra.     

Generation of oxodiazonium ions 1. Synthesis of [1,2,5]oxadiazolo[3,4-c]cinnoline 5-oxides

Methods for the synthesis of [1,2,5]oxadiazolo[3,4-c]cinnoline 5-oxides, which include the reaction of 3-nitramino-4-(R-phenyl)furazans or their O-methyl derivatives with electrophilic agents, have been developed. Unsubstituted [1,2,5]oxadiazolo[3,4-c]cinnoline 5-oxide was synthesized from 3-nitramino-4-phenylfurazan upon the action of phosphorus anhydride or oleum, as well as from O-methyl derivative of 3-nitramino-4-phenylfurazan upon the action of H₂SO₄, MeSO₃H, CF₃CO₂H and BF₃·Et₂O, while 6-, 7-, 8-, and 9-nitro-substituted [1,2,5]oxadiazolo[3,4-c]cinnoline 5-oxides — from the corresponding 3-nitramino-4-(nitrophenyl)furazans upon the action of the H₂SO₄-HNO₃ nitrating mixture. A suggestion has been made that an oxodiazonium ion is formed in these reactions from nitramines or their O-methyl derivatives upon the action of electrophilic agents, which is further involved into the intra-molecular reaction of electrophilic aromatic substitution (S _EAr) with the aryl group. The structure of [1,2,5]oxadiazolo[3,4-c]cinnoline 5-N-oxides was confirmed by ¹H, ¹³C, and ¹⁴N NMR spectra. Theoretical studies by the B3LYP/6-311G(d,p) method of combined molecular system (O-methylated 3-nitramino-4-phenylfurazan + [H₃SO₄]⁺) resulted in calculation of thermodynamic parameters of the sequence of cascade elementary reactions leading to the formation of [1,2,5]oxadiazolo[3,4-c]cinnoline 5-oxide.     

Biosynthesis of the cytochalasans. Part III. C-NMR. of cytochalasin B (phomin) and cytochalasin D. Incorporation of [1-13C]- and [2-13C]-sodium acetate

Sequential single frequency decoupling and partially relaxed Fourier transform (PRFT) are used to assign the natural abundance ¹³C-NMR. spectra of cytochalasin B (phomin) ( 1 ) and cytochalasin D ( 2 ). Cultures of Phoma spec. S 298 were fed [2-¹³C]-sodium acetate, and the distribution of this precursor in cytochalasin B (phomin) ( 1 ) was determined by ¹³C-NMR. spectroscopy. Likewise, the labelling patterns in cytochalasin D (zygosporin A) ( 2 ) from Zygos-posium masonii could be identified after incorporation of [2-¹³C]-sodium acetate and [l-¹³C]-sodium acetate. The results confirm previous proposals for the biogenesis of the cytochalasans from phenylalanine, methionine, and a C₁₈, or C₁₆, polyketide part.     

Phosphoramidites of Chiral (Rp)-and (Sp)-Configurated d(T[P-18O]-A): Synthesis,Configurational Assignment,and Use as Dimer Blocks in Oligonucleotide Synthesis

The N,N-diisopropylphosphoramidites 10a and 10b of appropriately protected chiral diastereoisomers of d(T[P-¹⁸O]-A) ( 8a and 8b , resp.), chiral by virtue of the isotope ¹⁸O at the P-atom, have been synthesized. The ¹⁸O-isotope was incorporated by oxidation of the phosphite triester 3 with H₂[¹⁸O]/I₂. Separation of the diastereoisomers was accomplished by flash chromatography of the O-3′-deprotected phosphate triesters 5a/b . The absolute configuration at the chiral P-atom was deduced from the methylation products of the fully deprotected diastereoisomers 8a and 8b . Phosphinylation of 5a and 5b yielded the configurationally pure phosphoramidites 10a and 10b , respectively, which were then employed in solid-phase synthesis to yield the self-complementary oligomers d(G-A-G-T-(R_p)-[P-¹⁸O]-A-C-T-C) ( 13 ) and d(G-A-G-T-(S_P)-[P-¹⁸O]-A-C-T-C) ( 14 ), respectively.     

Synthesis of dl-[2-13C]leucine and it use in the preparation of [3-dl-[2-13C]leucine]oxytocin and [8-dl-[2-13C]leucine]oxytocin: Preparative separation of diastereoisomeric peptides by partition chromatography and high pressure liquid chromatography

dl-[2-¹³C]Leucine was prepared by condensing the sodium salt of ethyl acetamido-[2-¹³C]cyanoacetate with isobutylbromide in hexamethylphosphoroustriamide followed by acid hydrolysis. N-Boc-dl-[2-¹³C]Leucine was prepared and incorporated into [8-dl-[2-¹³C]leucine]oxytocin by total synthesis. The ¹³C-labeled hormone derivative [8-[2-¹³C]leucine]oxytocin was separated from its 8-position diastereoisomer by partition chromatography. The specifically ¹³C-labeled peptide hormone diastereoisomeric analog [3-dl-[2-¹³C]leucine]oxytocin also was prepared by solid phase peptide synthesis. No suitable solvent system for partition chromatography separation of the latter diastereoisomeric peptide mixture could be found. However an excellent preparative separation of the diastereoisomers could be obtained by reverse phase high pressure liquid chromatography on a partisil 10 M9 ODS column using the solvent system 0.05 M ammonium acetate (pH 4.0), acetonitrile (81:19, $\text{v}\text{v}$) to give pure [3-(2-¹³C]leucine]oxytocin and [3-D-(2-¹³C]leucine]oxytocin. An excellent separation of [8[2-¹³C]leucine]oxytocin and the corresponding 8-D-leucine diastereoisomer derivative could also be accomplished by high pressure liquid chromatography.     

Radiolabeling of 1-[N',N'-bis(2-chloroethyl)-4-aminophenyl]-N-methyl-fullereno-C60-[1,9-c]pyrrolidine with 125I

Summary A procedure for labeling of a fullerene derivative 1-[N',N'-bis(2-chloroethyl)-4-aminophenyl]-N-methyl-fullereno-C₆₀-[1,9-c]pyrrolidine (C₆₀-C₁₃H₁₈N₂Cl₂) with ¹²⁵I is reported. The compound was first iodinated with a large excess of iodine monochloride and then radiolabeled by isotopic exchange with Na¹²⁵I in a toluene-water two-phase system. The dependence of the radiolabeling yield on the reaction temperature and exchange time was examined. The radiolabeling yield of the compound was as high as 94% after heating for 2 hours at 130 °C.     

Biosynthesis of kinamycin D. incorporation of [1,2-13C] acetate and of [2-2H3,1-13C]acetate

Results from the incorporation of [1,2-¹³C₂]- and [2-²H₃,1-¹³C]acetates into kinamycin D. indicate the involvement of only unsymmetrical intermediates; the identity of some of these are suggested.     

The mass spectra of [17-13C]phyllocladene and [3-13C]methylenecholestane—III

The mass spectra of [17-¹³C]phyllocladene and [3-¹³C]methylenecholestane have been examined. It is shown that there are some rearrangements at 70 e V as in the case of [17-¹³C]kaurene. However, no extensive randomization is evident at the molecular ion level. The results are interesting because very little is known about ¹³C randomization in polycyclic aliphatic hydrocarbons. The percentage retention of label was calculated for each ion.     

Synthesis and characterization of a new pillar[5]arene-based [1]rotaxane

In this study, we reported the synthesis of three kinds of mono-functional pillar[5]arene derivatives PRI, PRII and R and their structures were studied by 1D and 2D NMR spectra and mass spectra. The 2D NMR spectra including ¹H-¹³C HSQC, ¹H-¹H COSY and NOESY spectra indicated that PRI and PRII are both stable self-included pseudo[1]rotaxanes in CDCl₃. These original structures are promising compounds for the design of pillar[5]-based [1]rotaxane. And the results showed that R could exist stable in CDCl₃ and DMSO because of the coordination of N-H?O hydrogen bonding interaction and C-H?π interaction.